Skip to main content
OpenTrials
Completed

NCT Number: NCT05530993

Exploring the Perspectives and Experiences of PrEP-eligible Black Women in Texas in Relation to Readiness for PrEP Uptake and Adherence

The aim is to conduct two virtual focus groups (10 participants in each group) with 20 pre-exposure prophylaxis (PrEP)-eligible Black women in Houston and Austin, TX. Participants will be assigned to focus groups with other women based on their position about PrEP uptake (considered use versus not considered use). Focus group questions will build on an ecologic model framework to inquire about participant's intrapersonal, interpersonal, and community-level factors that influence access to and use of HIV prevention services. This strategy aims to examine potential barriers to PrEP uptake among PrEP-eligible women in two Texas' hotspots.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

PrEP Uptake Perspectives PrEP Adherence Experiences PrEP Adherence Perspectives PrEP Uptake Experiences

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

The University of Texas at Austin, Austin, Texas, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • assigned female sex at birth
  • identify as Black or African American
  • 18 years of age or older
  • have had condomless sex with a cisgender man within the past 12 months
  • fluent in English or Spanish
  • have a phone or internet access
  • not currently on PrEP and have never taken PrEP

Exclusion criteria

  • choose not to identify as Black or African American
  • unable to provide informed consent for participation (e.g. have severe cognitive impairment that would interfere with their ability to consent)
  • have psychological distress that would prohibit them from participating in the study
  • unable or unwilling to meet study requirements
  • ineligible for HIV prevention services [i.e., Human Immunodeficiency Virus (HIV) Positive]
  • received a prescription for PrEP within 12 months
  • has a history of PrEP uptake or is currently on PrEP

Treatment and study plan

Primary outcomes

  1. Facilitators to readiness to adopt PrEP

    Time frame: during the focus group

    A focus group will be used to identify facilitators to readiness to adopt PrEP (a focus group is a group interview among the study participants with the purpose of collecting information about a topic, in this case facilitators to readiness to adopt PrEP). During the focus group, focus group participants will be asked to indicate facilitators to readiness to adopt PrEP, and these facilitators to readiness will be recorded at the time of the focus group. These facilitators to readiness identified during the focus group will be reported categorically.

  2. Barriers to readiness to adopt PrEP

    Time frame: during the focus group

    A focus group will be used to identify barriers to readiness to adopt PrEP (a focus group is a group interview among the study participants with the purpose of collecting information about a topic, in this case barriers to readiness to adopt PrEP). During the focus group, focus group participants will be asked to indicate barriers to readiness to adopt PrEP, and these barriers to readiness will be recorded at the time of the focus group. These barriers to readiness identified during the focus group will be reported categorically.

Sponsors and collaborators

Lead sponsor

The University of Texas Health Science Center, Houston

Other

Collaborators

  • Merck Sharp & Dohme LLC

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Sep 7, 2022
Registry last updated
Nov 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.